Progenics Pharmaceuticals (PGNX) Q2 2014 Results - Earnings Call Webcast

Progenics Pharmaceuticals (NASDAQ:PGNX): Q2 EPS of -$0.17 misses by $0.03. Revenue of $1.5M (-16.7% Y/Y) misses by $1.33M.

The following audio is from a conference call that will begin on August 08, 2014 at 08:30 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.